Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Marengo CIMS Hospital

Verified

Basic Information

Site Overview

Source: Human-provided.

Care Institute of Medical Sciences (CIMS) in Ahmedabad is a well-established multi-specialty hospital with an active clinical research infrastructure and global trial experience. Its research centre has been involved in clinical trials for over a decade, conducting more than 120–130 studies including Phase III and Phase IV trials, registries, and medical device investigations. The site is supported by industry-standard infrastructure, experienced investigators, and dedicated full-time clinical research coordinators, enabling efficient study conduct across multiple therapeutic areas such as cardiology, pulmonology, oncology, orthopedics, and gastroenterology. The institution also supports research training and ongoing investigational programs, reflecting its strong focus on clinical innovation and evidence-based healthcare.

Source: Trial-derived.
19Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
11Active Trials
Source: Trial-derived.
7Completed Trials
Source: Trial-derived.
26Unique Conditions
Source: Trial-derived.
14Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Arthritis, Psoriatic (3)Source: Trial-derived. Stroke (2)Source: Trial-derived. Systemic Lupus Erythematosus (2)Source: Trial-derived. Acute Myocardial Infarction (AMI) (1)Source: Trial-derived. Advanced Non-Small Cell Lung Cancer (1)Source: Trial-derived. Atrial Fibrillation (1)Source: Trial-derived. Brain Diseases (1)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (4)Source: Trial-derived. Novo Nordisk A/S (3)Source: Trial-derived. Incyte Corporation (2)Source: Trial-derived. Janssen Research & Development, LLC (2)Source: Trial-derived. Mirati Therapeutics Inc. (2)Source: Trial-derived. Pfizer (2)Source: Trial-derived. Actelion (1)Source: Trial-derived. Duke Clinical Research Institute (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 46

Principal investigators

Source: Human-provided. 30

Study coordinators

Source: Human-provided. 13

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Radiation therapy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Brain imaging
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)